Preventing HIV/AIDS among high-risk urban women: the cost-effectiveness of a behavioral group intervention. Am J Public Health 1996 Oct;86(10):1442-5
Date
10/01/1996Pubmed ID
8876516Pubmed Central ID
PMC1380658DOI
10.2105/ajph.86.10.1442Abstract
OBJECTIVES: A human immunodeficiency virus (HIV) intervention trial for women at high risk for acquired immunodeficiency syndrome and attending an urban clinic was reported previously. The behavioral group intervention was shown to increase condom use behaviors significantly. This study retrospectively assessed the intervention's cost-effectiveness.
METHODS: Standard methods of cost and cost-utility analysis were used.
RESULTS: The intervention cost was just over $2000 for each quality-adjusted life-year saved; this is favorable compared with other life-saving programs. However, the results are sensitive to changes in some model assumptions.
CONCLUSIONS: Under most scenarios, the HIV prevention intervention was cost-effective.
Author List
Holtgrave DR, Kelly JAAuthor
Jeffrey A. Kelly PhD Professor in the Psychiatry and Behavioral Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Acquired Immunodeficiency SyndromeAdult
Condoms
Cost-Benefit Analysis
Female
Humans
Preventive Health Services
Quality-Adjusted Life Years
Retrospective Studies
Risk Factors
Sexual Behavior
Urban Population
